LEXINGTON, KY / ACCESSWIRE / November 21, 2024 / Cardiff Lexington Corporation (OTC PINK:CDIX) announced today financial results for its third quarter and nine months ended September 30, 2024. Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "Operationally, our business performed well during the quarter.
Significantly enhanced balance sheet positions company for long-term growth LEXINGTON, KY / ACCESSWIRE / August 20, 2024 / Cardiff Lexington Corporation (OTC PINK:CDIX) announced today financial results for its second quarter and six months ended June 30, 2024. Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "Our second quarter results were highlighted by a significantly improved balance sheet with shareholders' equity increasing to $5.8 million, 698% as compared to year end, as we strengthen our capital structure and position Cardiff Lexington for future growth.
FT. LAUDERDALE, FL / ACCESSWIRE / June 12, 2024 / Cardiff Lexington Corporation (OTC PINK:CDIX) today announced that it has entered into an agreement with GHS Investments, LLC. to cancel its Senior Secured Convertible Promissory Note, 8% Convertible Secured Redeemable Note and series R preferred stock in exchange for a new fixed amount settlement promissory note in the principal amount of $535,000.
| Capital Markets Industry | Financials Sector | Alex Hunt Cunningham CEO | OTC PINK Exchange | 14146R700 CUSIP |
| US Country | 17 Employees | - Last Dividend | 12 Sep 2014 Last Split | - IPO Date |
Cardiff Lexington Corporation operates primarily in the United States, engaging in the health care business along with its subsidiaries. The company has diversified its operations across Healthcare and Real Estate sectors. Originally known as Cardiff International, Inc., the company rebranded itself as Cardiff Lexington Corporation in January 2018 to better reflect its expansive portfolio. With its headquarters in Las Vegas, Nevada, Cardiff Lexington has positioned itself as a multifaceted entity offering a range of services from tax resolution to healthcare and commercial real estate.
This service is aimed at individuals and companies facing federal and state tax liabilities. Cardiff Lexington Corporation extends professional assistance to navigate the complexities of tax laws, helping clients to resolve their tax issues efficiently.
The company offers an extensive range of diagnostic and surgical services tailored for injuries and disorders affecting the skeletal system. This includes care for associated bones, joints, tendons, muscles, ligaments, and nerves, providing comprehensive treatment for musculoskeletal ailments.
Cardiff Lexington Corporation is also engaged in the commercial real estate sector. This segment involves the acquisition, development, and management of commercial real estate properties, showcasing the company’s versatility beyond its primary healthcare business.